ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm

by Anumana, Inc.  · Based in United States → — Unlocking the Language of the Heart
Cardiology Hospital Medicine Internal Medicine

Regulatory Status Disclosed

Overview

The Anumana ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm is a software as a medical device (SaMD) designed to assist clinicians in identifying adult patients who may be at risk for Cardiac Amyloidosis (CA) using a standard 12-lead electrocardiogram (ECG).

  • What it does:This AI-enabled algorithm analyzes ECG waveforms to detect patterns associated with CA that may not be apparent through human interpretation. It is intended to aid in earlier detection of CA in adults being evaluated for signs or symptoms consistent with the condition, including those with unexplained heart failure, nephrotic syndrome, peripheral neuropathy, arrhythmias, or aortic stenosis.
  • Who it is for:The tool is relevant for various specialties and care settings where patients are evaluated for cardiac symptoms, particularly those with comorbidities associated with CA. This includes cardiologists, primary care physicians, and other clinicians in hospital or outpatient settings.
  • How it fits a clinical or practice workflow:The algorithm integrates into existing clinical workflows by utilizing standard 12-lead ECGs that are routinely obtained in practice, without requiring additional testing. It is not intended as a standalone diagnostic tool but rather to support clinicians in identifying patients who may benefit from further evaluation for CA.
  • Notable capabilities:The ECG-AI CA algorithm was developed at Mayo Clinic and validated in a multi-center study.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-driven analysis of standard 12-lead ECGs
  • Detects cardiac disease signals invisible to the human eye
  • Integrates with existing clinical workflows and EHRs
  • Aids in earlier detection of Cardiac Amyloidosis
  • Software as a Medical Device (SaMD)
  • Clinically validated with extensive evidence base
  • Supports clinical decision-making at the point of care
  • Eligible for reimbursement

Use Cases

  • Early identification of cardiac amyloidosis in adults being evaluated for consistent signs or symptoms
  • Screening patients with conditions commonly associated with cardiac amyloidosis (e.g., unexplained heart failure, nephrotic syndrome, peripheral neuropathy, arrhythmias, aortic stenosis)
  • Supporting clinicians in recognizing suspicion of cardiac amyloidosis from routine ECGs
  • Guiding further clinical evaluation for at-risk patients

What Physicians Need to Know

ECG/EKG Analysis Capability
Analyzes standard 12-lead ECGs to detect patterns indicative of Cardiac Amyloidosis, revealing insights beyond human detection capabilities.
Heart Failure Risk Prediction
The platform's algorithms provide clinically validated insights that help enable earlier intervention and improved patient outcomes by identifying at-risk patients earlier.
Physician Tip

This tool transforms standard 12-lead ECGs into a powerful tool for assessing cardiac conditions like Cardiac Amyloidosis. It integrates seamlessly into existing workflows and EHR systems, providing instant results to support ongoing patient care without requiring new systems or disruptions.

Anumana's platform is designed for seamless and secure integration directly within your EHR and on your own servers. It supports EHR configuration for orderables, results viewing, and HL7 data exchange. It also integrates with ECG Management Systems by processing digital waveform files (XML or DICOM) within the system framework, ensuring no PHI data is exported for external processing.

Details

Category Cardiology AI, Clinical Decision Support & Reference
Pricing Unknown
DeploymentIntegrated with existing ECG management systems and EHR environments
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Cardiology, Hospital Medicine, Internal Medicine

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm.

Loading videos...

View all on YouTube

Frequently Asked Questions

The algorithm integrates directly within your EHR and runs securely inside your environment, ensuring no disruption to current ECG orders and lab processes.
It works with many ECG systems commonly used in clinical practice and can be configured for digital waveform files (XML or DICOM) for automated processing.
Setup involves configuring virtual machine requirements, network access, and installing the ECG-AI framework software within your IT infrastructure.
It is designed to help clinicians identify at-risk patients earlier by unlocking clinical insights from every heartbeat.
The AI engine analyzes ECG data points and delivers binary findings to support ongoing care, with instant results flowing directly into your EHR.

Related Tools

Stethophone Pro
Sparrow Acoustics
Cardiology AI
Stethophone Pro transforms smartphones into advanced cardiac screening tools, enabling clinicians to capture, interpret, and visualize heart sounds for early detection of cardiovascular diseases.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System, ACUSON Origin ICE Diagnostic Ultrasound System
Siemens Medical Solutions, USA
Cardiology AI
Siemens Healthineers offers advanced AI-powered ultrasound systems, including the ACUSON Origin for comprehensive cardiovascular care and the ACUSON Sequoia for high-performance general imaging with BioAcoustic™ technology.
syngo.via MI Workflows, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, syngo MBF is an intelligent, integrated imaging software that helps address the challenges of interpreting, managing, and sharing complex data from molecular imaging scanners, providing automated workflows and advanced visualization for various clinical applications.
syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System
Siemens Medical Solutions USA
Cardiology AI
Siemens Healthineers offers the ACUSON Sequoia, ACUSON Sequoia Select, and ACUSON Origin ultrasound systems, providing advanced imaging for various medical needs. The Sequoia line focuses on high-resolution imaging with deep penetration and reduced variability, while the AI-powered ACUSON Origin specializes in comprehensive cardiovascular diagnostics and interventions.
R30 Diagnostic Ultrasound System
Samsung Medison Co.
Cardiology AI
The Samsung Medison R30 Diagnostic Ultrasound System is a general-purpose, mobile, software-controlled diagnostic ultrasound system that offers a wide range of imaging capabilities and analysis tools for various clinical applications.

See all Cardiology AI tools →

More from Anumana

ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm
Anumana
Cardiology AI
An AI algorithm that analyzes standard 12-lead ECG recordings to detect signs of pulmonary hypertension, aiming for earlier diagnosis and improved patient outcomes.
Low Ejection Fraction AI-ECG Algorithm
Anumana
Cardiology AI
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-09-23 | First Added: 2026-09-23
AI Tool Finder
AI-powered search. Results may not be comprehensive.